1. Eltrombopag interferes with bilirubin and/or creatinine results

   News item 24 November 2018 Pages: 1 - 1

2. EMA releases guidance for PV monitoring in paediatrics

   News item 24 November 2018 Pages: 2 - 2

3. Increased risk of fracture, deaths with Xofigo: Canadian alert

   News item 24 November 2018 Pages: 3 - 3

4. Anhypertensives in low-risk patients: caution advised

   Clinical study 24 November 2018 Pages: 4 - 4

5. Etanercept safe and well tolerated in juvenile arthritis

   Clinical study 24 November 2018 Pages: 5 - 5

6. Hospitalisation of elderly linked with inappropriate prescribing

   Clinical study 24 November 2018 Pages: 6 - 6

7. Immune checkpoint inhibitors: risk of severe cardiovascular events

   Clinical study 24 November 2018 Pages: 7 - 7

8. Pharmacist-led intervention reduces inappropriate prescribing

   Clinical study 24 November 2018 Pages: 8 - 8

9. Risk of CIPN among women with breast cancer: Medicare data

   Clinical study 24 November 2018 Pages: 9 - 9

10. SGLT2 inhibitors: doubling of risks of serious adverse events

    Clinical study 24 November 2018 Pages: 10 - 10

11. Short-term oseltamivir triggers neuropsychiatric adverse events

    Clinical study 24 November 2018 Pages: 11 - 11

12. Abemaciclib

    Case report 24 November 2018 Pages: 12 - 12

13. Acetylcysteine/mecobalamin/methylfolate

    Case report 24 November 2018 Pages: 13 - 13

14. Adalimumab

    Case report 24 November 2018 Pages: 14 - 14

15. Adalimumab

    Case report 24 November 2018 Pages: 15 - 15

16. Adalimumab/certolizumab-pegol

    Case report 24 November 2018 Pages: 16 - 16

17. Alemtuzumab

    Case report 24 November 2018 Pages: 17 - 17

18. Alemtuzumab

    Case report 24 November 2018 Pages: 18 - 18

19. Allopurinol/methylprednisolone/prednisone

    Case report 24 November 2018 Pages: 19 - 19

20. Alteplase/heparin

    Case report 24 November 2018 Pages: 20 - 20

21. Amfetamine/dexamfetamine/clonidine

    Case report 24 November 2018 Pages: 21 - 21

22. Ampicillin/sulbactam

    Case report 24 November 2018 Pages: 22 - 22

23. Anti-inflammatories/antineoplastics

    Case report 24 November 2018 Pages: 23 - 23

24. Antibacterials

    Case report 24 November 2018 Pages: 24 - 24

25. Antiepileptics/levobupivacaine/propofol

    Case report 24 November 2018 Pages: 25 - 25

26. Antineoplastics

    Case report 24 November 2018 Pages: 26 - 26

27. Antineoplastics

    Case report 24 November 2018 Pages: 27 - 27

28. Antineoplastics

    Case report 24 November 2018 Pages: 28 - 28

29. Antineoplastics

    Case report 24 November 2018 Pages: 29 - 29

30. Antineoplastics

    Case report 24 November 2018 Pages: 30 - 30

31. Antineoplastics

    Case report 24 November 2018 Pages: 31 - 31

32. Antineoplastics

    Case report 24 November 2018 Pages: 32 - 32

33. Antineoplastics

    Case report 24 November 2018 Pages: 33 - 33

34. Antineoplastics

    Case report 24 November 2018 Pages: 34 - 34

35. Antituberculars

    Case report 24 November 2018 Pages: 35 - 35

36. Arsenic trioxide/tretinoin

    Case report 24 November 2018 Pages: 36 - 36

37. Aspirin/warfarin

    Case report 24 November 2018 Pages: 37 - 37

38. Atazanavir

    Case report 24 November 2018 Pages: 38 - 38

39. Atezolizumab

    Case report 24 November 2018 Pages: 39 - 39

40. Atropine

    Case report 24 November 2018 Pages: 40 - 40

41. Azathioprine

    Case report 24 November 2018 Pages: 41 - 41

42. Azathioprine/pamidronic-acid

    Case report 24 November 2018 Pages: 42 - 42

43. Baclofen

    Case report 24 November 2018 Pages: 43 - 43

44. Barium

    Case report 24 November 2018 Pages: 44 - 44

45. BCG

    Case report 24 November 2018 Pages: 45 - 45

46. BCG vaccine

    Case report 24 November 2018 Pages: 46 - 46

47. BCG vaccine/methylprednisolone

    Case report 24 November 2018 Pages: 47 - 47

48. Benzocaine

    Case report 24 November 2018 Pages: 48 - 48

49. Bevacizumab

    Case report 24 November 2018 Pages: 49 - 49

50. Bevacizumab

    Case report 24 November 2018 Pages: 50 - 50